Mrv1909 11291917072D 8 8 0 0 0 0 999 V2000 -0.0316 0.1387 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.2864 0.9233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7704 -0.1218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6991 -0.3461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.1114 0.9233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9248 -0.9233 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3663 0.4357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.3663 0.1386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 1 1 0 0 0 1 4 1 0 0 0 0 2 5 1 0 0 0 0 3 6 1 0 0 0 0 3 7 2 0 0 0 0 4 8 1 0 0 0 0 5 8 1 0 0 0 0 M END > DBMET00494 > drugbank > OC(=O)[C@@H]1CCCN1 > InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1 > ONIBWKKTOPOVIA-BYPYZUCNSA-N > C5H9NO2 > 115.1305 > 115.063328537 > 3 > 17 > 11.50403298353395 > 1 > 2 > 0 > 0 > (2S)-pyrrolidine-2-carboxylic acid > -2.71 > -2.568638276039985 > 0.50 > 0 > 1 > 0 > 1.9406707712827915 > 11.332026115136207 > 49.33 > 28.064299999999996 > 1 > 1 > 3.65e+02 g/l > palladium(2+) (4S,5S,14R,15R)-10-acetyl-4-(2-carboxyethyl)-15-ethyl-2-(2-methoxy-2-oxoethyl)-5,9,14,19-tetramethyl-20-[(2-sulfoethyl)carbamoyl]-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3(24),6,8,10,12,16(22),17,19-nonaene-21,23-diide > 0 > DBMET00494 > Proline $$$$